314 related articles for article (PubMed ID: 16462803)
1. Design and use of conditional MHC class I ligands.
Toebes M; Coccoris M; Bins A; Rodenko B; Gomez R; Nieuwkoop NJ; van de Kasteele W; Rimmelzwaan GF; Haanen JB; Ovaa H; Schumacher TN
Nat Med; 2006 Feb; 12(2):246-51. PubMed ID: 16462803
[TBL] [Abstract][Full Text] [Related]
2. Class I major histocompatibility complexes loaded by a periodate trigger.
Rodenko B; Toebes M; Celie PH; Perrakis A; Schumacher TN; Ovaa H
J Am Chem Soc; 2009 Sep; 131(34):12305-13. PubMed ID: 19655751
[TBL] [Abstract][Full Text] [Related]
3. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
5. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.
Rodenko B; Toebes M; Hadrup SR; van Esch WJ; Molenaar AM; Schumacher TN; Ovaa H
Nat Protoc; 2006; 1(3):1120-32. PubMed ID: 17406393
[TBL] [Abstract][Full Text] [Related]
6. UV-induced ligand exchange in MHC class I protein crystals.
Celie PH; Toebes M; Rodenko B; Ovaa H; Perrakis A; Schumacher TN
J Am Chem Soc; 2009 Sep; 131(34):12298-304. PubMed ID: 19655750
[TBL] [Abstract][Full Text] [Related]
7. Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Douat-Casassus C; Marchand-Geneste N; Diez E; Gervois N; Jotereau F; Quideau S
J Med Chem; 2007 Apr; 50(7):1598-609. PubMed ID: 17328535
[TBL] [Abstract][Full Text] [Related]
8. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
9. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
10. Enhancing cytotoxic T cell responses with altered-peptide ligands.
Zhao R; Collins EJ
Arch Immunol Ther Exp (Warsz); 2001; 49(4):271-7. PubMed ID: 11726029
[TBL] [Abstract][Full Text] [Related]
11. Structural implications for the design of molecular vaccines.
Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
[TBL] [Abstract][Full Text] [Related]
12. Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?
Uhlin M; Masucci M; Levitsky V
Scand J Immunol; 2006 Dec; 64(6):581-7. PubMed ID: 17083613
[TBL] [Abstract][Full Text] [Related]
13. Function-related regulation of the stability of MHC proteins.
Simon A; Dosztányi Zs; Rajnavölgyi E; Simon I
Biophys J; 2000 Nov; 79(5):2305-13. PubMed ID: 11053110
[TBL] [Abstract][Full Text] [Related]
14. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
[TBL] [Abstract][Full Text] [Related]
15. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
16. Structural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A Virus.
Wu Y; Wang J; Fan S; Chen R; Liu Y; Zhang J; Yuan H; Liang R; Zhang N; Xia C
J Virol; 2017 Jul; 91(14):. PubMed ID: 28490583
[TBL] [Abstract][Full Text] [Related]
17. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
Rötzschke O; Falk K; Stevanović S; Grahovac B; Soloski MJ; Jung G; Rammensee HG
Nature; 1993 Feb; 361(6413):642-4. PubMed ID: 8437623
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
19. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
